世界の個別化医療におけるナノ材料市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Nanomaterials in Personalized Medicine Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5262 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、個別化医療におけるナノ材料の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ナノメディシン、ナノメートル医療機器、その他）、用途別市場規模（抗がん剤、CNS製品、抗感染症、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・個別化医療におけるナノ材料の市場動向 ・企業の競争状況、市場シェア ・個別化医療におけるナノ材料の種類別市場規模と予測2016-2027（ナノメディシン、ナノメートル医療機器、その他） ・個別化医療におけるナノ材料の用途別市場規模と予測2016-2027（抗がん剤、CNS製品、抗感染症、その他） ・個別化医療におけるナノ材料の北米市場規模2016-2027（アメリカ、カナダ） ・個別化医療におけるナノ材料の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・個別化医療におけるナノ材料のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・個別化医療におけるナノ材料の中南米市場規模2016-2027（メキシコ、ブラジル） ・個別化医療におけるナノ材料の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Abbott、Amgen、Biogen、Celgene、Gilead Sciences、Merck and Co、Pfizer、Roche、Sanofi、Stryker、Teva Pharmaceuticals） ・結論

The use of nanotechnology offers new opportunities for the development of novel strategies in terms of prevention, diagnosis, and treatment viral infections.

Market Analysis and Insights: Global Nanomaterials in Personalized Medicine Market
The global Nanomaterials in Personalized Medicine market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Nanomaterials in Personalized Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Nanomaterials in Personalized Medicine market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Nanomaterials in Personalized Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Nanomaterials in Personalized Medicine market.

Global Nanomaterials in Personalized Medicine Scope and Market Size
Nanomaterials in Personalized Medicine market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Nanomaterials in Personalized Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Nano-Medicine
Nanometer Medical Instrument
Others

Segment by Application
Anticancer
CNS Products
Anti-infection
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Abbott
Amgen
Biogen
Celgene
Gilead Sciences
Merck and Co
Pfizer
Roche
Sanofi
Stryker
Teva Pharmaceuticals

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Nanomaterials in Personalized Medicine Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Nano-Medicine
1.2.3 Nanometer Medical Instrument
1.2.4 Others
1.3 Market by Application
1.3.1 Global Nanomaterials in Personalized Medicine Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Anticancer
1.3.3 CNS Products
1.3.4 Anti-infection
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Nanomaterials in Personalized Medicine Market Perspective (2016-2027)
2.2 Nanomaterials in Personalized Medicine Growth Trends by Regions
2.2.1 Nanomaterials in Personalized Medicine Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Nanomaterials in Personalized Medicine Historic Market Share by Regions (2016-2021)
2.2.3 Nanomaterials in Personalized Medicine Forecasted Market Size by Regions (2022-2027)
2.3 Nanomaterials in Personalized Medicine Industry Dynamic
2.3.1 Nanomaterials in Personalized Medicine Market Trends
2.3.2 Nanomaterials in Personalized Medicine Market Drivers
2.3.3 Nanomaterials in Personalized Medicine Market Challenges
2.3.4 Nanomaterials in Personalized Medicine Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Nanomaterials in Personalized Medicine Players by Revenue
3.1.1 Global Top Nanomaterials in Personalized Medicine Players by Revenue (2016-2021)
3.1.2 Global Nanomaterials in Personalized Medicine Revenue Market Share by Players (2016-2021)
3.2 Global Nanomaterials in Personalized Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Nanomaterials in Personalized Medicine Revenue
3.4 Global Nanomaterials in Personalized Medicine Market Concentration Ratio
3.4.1 Global Nanomaterials in Personalized Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Nanomaterials in Personalized Medicine Revenue in 2020
3.5 Nanomaterials in Personalized Medicine Key Players Head office and Area Served
3.6 Key Players Nanomaterials in Personalized Medicine Product Solution and Service
3.7 Date of Enter into Nanomaterials in Personalized Medicine Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Nanomaterials in Personalized Medicine Breakdown Data by Type
4.1 Global Nanomaterials in Personalized Medicine Historic Market Size by Type (2016-2021)
4.2 Global Nanomaterials in Personalized Medicine Forecasted Market Size by Type (2022-2027)

5 Nanomaterials in Personalized Medicine Breakdown Data by Application
5.1 Global Nanomaterials in Personalized Medicine Historic Market Size by Application (2016-2021)
5.2 Global Nanomaterials in Personalized Medicine Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Nanomaterials in Personalized Medicine Market Size (2016-2027)
6.2 North America Nanomaterials in Personalized Medicine Market Size by Type
6.2.1 North America Nanomaterials in Personalized Medicine Market Size by Type (2016-2021)
6.2.2 North America Nanomaterials in Personalized Medicine Market Size by Type (2022-2027)
6.2.3 North America Nanomaterials in Personalized Medicine Market Size by Type (2016-2027)
6.3 North America Nanomaterials in Personalized Medicine Market Size by Application
6.3.1 North America Nanomaterials in Personalized Medicine Market Size by Application (2016-2021)
6.3.2 North America Nanomaterials in Personalized Medicine Market Size by Application (2022-2027)
6.3.3 North America Nanomaterials in Personalized Medicine Market Size by Application (2016-2027)
6.4 North America Nanomaterials in Personalized Medicine Market Size by Country
6.4.1 North America Nanomaterials in Personalized Medicine Market Size by Country (2016-2021)
6.4.2 North America Nanomaterials in Personalized Medicine Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Nanomaterials in Personalized Medicine Market Size (2016-2027)
7.2 Europe Nanomaterials in Personalized Medicine Market Size by Type
7.2.1 Europe Nanomaterials in Personalized Medicine Market Size by Type (2016-2021)
7.2.2 Europe Nanomaterials in Personalized Medicine Market Size by Type (2022-2027)
7.2.3 Europe Nanomaterials in Personalized Medicine Market Size by Type (2016-2027)
7.3 Europe Nanomaterials in Personalized Medicine Market Size by Application
7.3.1 Europe Nanomaterials in Personalized Medicine Market Size by Application (2016-2021)
7.3.2 Europe Nanomaterials in Personalized Medicine Market Size by Application (2022-2027)
7.3.3 Europe Nanomaterials in Personalized Medicine Market Size by Application (2016-2027)
7.4 Europe Nanomaterials in Personalized Medicine Market Size by Country
7.4.1 Europe Nanomaterials in Personalized Medicine Market Size by Country (2016-2021)
7.4.2 Europe Nanomaterials in Personalized Medicine Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Nanomaterials in Personalized Medicine Market Size (2016-2027)
8.2 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Type
8.2.1 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Type (2016-2027)
8.3 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Application
8.3.1 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Application (2016-2027)
8.4 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Region
8.4.1 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Nanomaterials in Personalized Medicine Market Size (2016-2027)
9.2 Latin America Nanomaterials in Personalized Medicine Market Size by Type
9.2.1 Latin America Nanomaterials in Personalized Medicine Market Size by Type (2016-2021)
9.2.2 Latin America Nanomaterials in Personalized Medicine Market Size by Type (2022-2027)
9.2.3 Latin America Nanomaterials in Personalized Medicine Market Size by Type (2016-2027)
9.3 Latin America Nanomaterials in Personalized Medicine Market Size by Application
9.3.1 Latin America Nanomaterials in Personalized Medicine Market Size by Application (2016-2021)
9.3.2 Latin America Nanomaterials in Personalized Medicine Market Size by Application (2022-2027)
9.3.3 Latin America Nanomaterials in Personalized Medicine Market Size by Application (2016-2027)
9.4 Latin America Nanomaterials in Personalized Medicine Market Size by Country
9.4.1 Latin America Nanomaterials in Personalized Medicine Market Size by Country (2016-2021)
9.4.2 Latin America Nanomaterials in Personalized Medicine Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Nanomaterials in Personalized Medicine Market Size (2016-2027)
10.2 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Type
10.2.1 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Type (2016-2027)
10.3 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Application
10.3.1 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Application (2016-2027)
10.4 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Country
10.4.1 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Abbott
11.1.1 Abbott Company Details
11.1.2 Abbott Business Overview
11.1.3 Abbott Nanomaterials in Personalized Medicine Introduction
11.1.4 Abbott Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.1.5 Abbott Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Nanomaterials in Personalized Medicine Introduction
11.2.4 Amgen Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 Biogen
11.3.1 Biogen Company Details
11.3.2 Biogen Business Overview
11.3.3 Biogen Nanomaterials in Personalized Medicine Introduction
11.3.4 Biogen Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.3.5 Biogen Recent Development
11.4 Celgene
11.4.1 Celgene Company Details
11.4.2 Celgene Business Overview
11.4.3 Celgene Nanomaterials in Personalized Medicine Introduction
11.4.4 Celgene Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.4.5 Celgene Recent Development
11.5 Gilead Sciences
11.5.1 Gilead Sciences Company Details
11.5.2 Gilead Sciences Business Overview
11.5.3 Gilead Sciences Nanomaterials in Personalized Medicine Introduction
11.5.4 Gilead Sciences Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.5.5 Gilead Sciences Recent Development
11.6 Merck and Co
11.6.1 Merck and Co Company Details
11.6.2 Merck and Co Business Overview
11.6.3 Merck and Co Nanomaterials in Personalized Medicine Introduction
11.6.4 Merck and Co Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.6.5 Merck and Co Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Details
11.7.2 Pfizer Business Overview
11.7.3 Pfizer Nanomaterials in Personalized Medicine Introduction
11.7.4 Pfizer Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.7.5 Pfizer Recent Development
11.8 Roche
11.8.1 Roche Company Details
11.8.2 Roche Business Overview
11.8.3 Roche Nanomaterials in Personalized Medicine Introduction
11.8.4 Roche Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.8.5 Roche Recent Development
11.9 Sanofi
11.9.1 Sanofi Company Details
11.9.2 Sanofi Business Overview
11.9.3 Sanofi Nanomaterials in Personalized Medicine Introduction
11.9.4 Sanofi Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.9.5 Sanofi Recent Development
11.10 Stryker
11.10.1 Stryker Company Details
11.10.2 Stryker Business Overview
11.10.3 Stryker Nanomaterials in Personalized Medicine Introduction
11.10.4 Stryker Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.10.5 Stryker Recent Development
11.11 Teva Pharmaceuticals
11.11.1 Teva Pharmaceuticals Company Details
11.11.2 Teva Pharmaceuticals Business Overview
11.11.3 Teva Pharmaceuticals Nanomaterials in Personalized Medicine Introduction
11.11.4 Teva Pharmaceuticals Revenue in Nanomaterials in Personalized Medicine Business (2016-2021)
11.11.5 Teva Pharmaceuticals Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Nanomaterials in Personalized Medicine Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Nano-Medicine
Table 3. Key Players of Nanometer Medical Instrument
Table 4. Key Players of Others
Table 5. Global Nanomaterials in Personalized Medicine Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Nanomaterials in Personalized Medicine Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Nanomaterials in Personalized Medicine Market Size by Regions (2016-2021) & (US$ Million)
Table 8. Global Nanomaterials in Personalized Medicine Market Share by Regions (2016-2021)
Table 9. Global Nanomaterials in Personalized Medicine Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 10. Global Nanomaterials in Personalized Medicine Market Share by Regions (2022-2027)
Table 11. Nanomaterials in Personalized Medicine Market Trends
Table 12. Nanomaterials in Personalized Medicine Market Drivers
Table 13. Nanomaterials in Personalized Medicine Market Challenges
Table 14. Nanomaterials in Personalized Medicine Market Restraints
Table 15. Global Nanomaterials in Personalized Medicine Revenue by Players (2016-2021) & (US$ Million)
Table 16. Global Nanomaterials in Personalized Medicine Market Share by Players (2016-2021)
Table 17. Global Top Nanomaterials in Personalized Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomaterials in Personalized Medicine as of 2020)
Table 18. Ranking of Global Top Nanomaterials in Personalized Medicine Companies by Revenue (US$ Million) in 2020
Table 19. Global 5 Largest Players Market Share by Nanomaterials in Personalized Medicine Revenue (CR5 and HHI) & (2016-2021)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Nanomaterials in Personalized Medicine Product Solution and Service
Table 22. Date of Enter into Nanomaterials in Personalized Medicine Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Nanomaterials in Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 25. Global Nanomaterials in Personalized Medicine Revenue Market Share by Type (2016-2021)
Table 26. Global Nanomaterials in Personalized Medicine Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 27. Global Nanomaterials in Personalized Medicine Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 28. Global Nanomaterials in Personalized Medicine Market Size Share by Application (2016-2021) & (US$ Million)
Table 29. Global Nanomaterials in Personalized Medicine Revenue Market Share by Application (2016-2021)
Table 30. Global Nanomaterials in Personalized Medicine Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 31. Global Nanomaterials in Personalized Medicine Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 32. North America Nanomaterials in Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 33. North America Nanomaterials in Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 34. North America Nanomaterials in Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
Table 35. North America Nanomaterials in Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 36. North America Nanomaterials in Personalized Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 37. North America Nanomaterials in Personalized Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 38. Europe Nanomaterials in Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 39. Europe Nanomaterials in Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 40. Europe Nanomaterials in Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
Table 41. Europe Nanomaterials in Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 42. Europe Nanomaterials in Personalized Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 43. Europe Nanomaterials in Personalized Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 44. Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 45. Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 46. Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
Table 47. Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 48. Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Region (2016-2021) & (US$ Million)
Table 49. Asia-Pacific Nanomaterials in Personalized Medicine Market Size by Region (2022-2027) & (US$ Million)
Table 50. Latin America Nanomaterials in Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 51. Latin America Nanomaterials in Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 52. Latin America Nanomaterials in Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
Table 53. Latin America Nanomaterials in Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 54. Latin America Nanomaterials in Personalized Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 55. Latin America Nanomaterials in Personalized Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 56. Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Type (2016-2021) (US$ Million)
Table 57. Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Type (2022-2027) & (US$ Million)
Table 58. Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Application (2016-2021) (US$ Million)
Table 59. Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Application (2022-2027) & (US$ Million)
Table 60. Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Country (2016-2021) & (US$ Million)
Table 61. Middle East & Africa Nanomaterials in Personalized Medicine Market Size by Country (2022-2027) & (US$ Million)
Table 62. Abbott Company Details
Table 63. Abbott Business Overview
Table 64. Abbott Nanomaterials in Personalized Medicine Product
Table 65. Abbott Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 66. Abbott Recent Development
Table 67. Amgen Company Details
Table 68. Amgen Business Overview
Table 69. Amgen Nanomaterials in Personalized Medicine Product
Table 70. Amgen Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 71. Amgen Recent Development
Table 72. Biogen Company Details
Table 73. Biogen Business Overview
Table 74. Biogen Nanomaterials in Personalized Medicine Product
Table 75. Biogen Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 76. Biogen Recent Development
Table 77. Celgene Company Details
Table 78. Celgene Business Overview
Table 79. Celgene Nanomaterials in Personalized Medicine Product
Table 80. Celgene Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 81. Celgene Recent Development
Table 82. Gilead Sciences Company Details
Table 83. Gilead Sciences Business Overview
Table 84. Gilead Sciences Nanomaterials in Personalized Medicine Product
Table 85. Gilead Sciences Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 86. Gilead Sciences Recent Development
Table 87. Merck and Co Company Details
Table 88. Merck and Co Business Overview
Table 89. Merck and Co Nanomaterials in Personalized Medicine Product
Table 90. Merck and Co Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 91. Merck and Co Recent Development
Table 92. Pfizer Company Details
Table 93. Pfizer Business Overview
Table 94. Pfizer Nanomaterials in Personalized Medicine Product
Table 95. Pfizer Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 96. Pfizer Recent Development
Table 97. Roche Company Details
Table 98. Roche Business Overview
Table 99. Roche Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 100. Roche Recent Development
Table 101. Sanofi Company Details
Table 102. Sanofi Business Overview
Table 103. Sanofi Nanomaterials in Personalized Medicine Product
Table 104. Sanofi Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 105. Sanofi Recent Development
Table 106. Stryker Company Details
Table 107. Stryker Business Overview
Table 108. Stryker Nanomaterials in Personalized Medicine Product
Table 109. Stryker Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 110. Stryker Recent Development
Table 111. Teva Pharmaceuticals Company Details
Table 112. Teva Pharmaceuticals Business Overview
Table 113. Teva Pharmaceuticals Nanomaterials in Personalized Medicine Product
Table 114. Teva Pharmaceuticals Revenue in Nanomaterials in Personalized Medicine Business (2016-2021) & (US$ Million)
Table 115. Teva Pharmaceuticals Recent Development
Table 116. Research Programs/Design for This Report
Table 117. Key Data Information from Secondary Sources
Table 118. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Nanomaterials in Personalized Medicine Market Share by Type: 2020 VS 2027
Figure 2. Nano-Medicine Features
Figure 3. Nanometer Medical Instrument Features
Figure 4. Others Features
Figure 5. Global Nanomaterials in Personalized Medicine Market Share by Application: 2020 VS 2027
Figure 6. Anticancer Case Studies
Figure 7. CNS Products Case Studies
Figure 8. Anti-infection Case Studies
Figure 9. Others Case Studies
Figure 10. Nanomaterials in Personalized Medicine Report Years Considered
Figure 11. Global Nanomaterials in Personalized Medicine Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Nanomaterials in Personalized Medicine Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Nanomaterials in Personalized Medicine Market Share by Regions: 2020 VS 2027
Figure 14. Global Nanomaterials in Personalized Medicine Market Share by Regions (2022-2027)
Figure 15. Global Nanomaterials in Personalized Medicine Market Share by Players in 2020
Figure 16. Global Top Nanomaterials in Personalized Medicine Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Nanomaterials in Personalized Medicine as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Nanomaterials in Personalized Medicine Revenue in 2020
Figure 18. Global Nanomaterials in Personalized Medicine Revenue Market Share by Type (2016-2021)
Figure 19. Global Nanomaterials in Personalized Medicine Revenue Market Share by Type (2022-2027)
Figure 20. North America Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Nanomaterials in Personalized Medicine Market Share by Type (2016-2027)
Figure 22. North America Nanomaterials in Personalized Medicine Market Share by Application (2016-2027)
Figure 23. North America Nanomaterials in Personalized Medicine Market Share by Country (2016-2027)
Figure 24. United States Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Nanomaterials in Personalized Medicine Market Share by Type (2016-2027)
Figure 28. Europe Nanomaterials in Personalized Medicine Market Share by Application (2016-2027)
Figure 29. Europe Nanomaterials in Personalized Medicine Market Share by Country (2016-2027)
Figure 30. Germany Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Nanomaterials in Personalized Medicine Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Nanomaterials in Personalized Medicine Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Nanomaterials in Personalized Medicine Market Share by Region (2016-2027)
Figure 40. China Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Nanomaterials in Personalized Medicine Market Share by Type (2016-2027)
Figure 48. Latin America Nanomaterials in Personalized Medicine Market Share by Application (2016-2027)
Figure 49. Latin America Nanomaterials in Personalized Medicine Market Share by Country (2016-2027)
Figure 50. Mexico Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Nanomaterials in Personalized Medicine Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Nanomaterials in Personalized Medicine Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Nanomaterials in Personalized Medicine Market Share by Country (2016-2027)
Figure 56. Turkey Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Nanomaterials in Personalized Medicine Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Abbott Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 60. Amgen Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 61. Biogen Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 62. Celgene Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 63. Gilead Sciences Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 64. Merck and Co Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 65. Pfizer Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 66. Roche Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 67. Sanofi Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 68. Stryker Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 69. Teva Pharmaceuticals Revenue Growth Rate in Nanomaterials in Personalized Medicine Business (2016-2021)
Figure 70. Bottom-up and Top-down Approaches for This Report
Figure 71. Data Triangulation
Figure 72. Key Executives Interviewed

---